Clinical Trials Directory

Trials / Sponsors / GC Biopharma Corp

GC Biopharma Corp

Industry · 13 registered clinical trials — 5 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in He
Varicella (Chickenpox), Chickenpox Vaccine
Phase 32026-03-17
RecruitingA Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults
Tetanus-diphtheria-acellular Pertussis (Tdap)
Phase 1 / Phase 22025-06-05
RecruitingA proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
Fabry Disesase
Phase 1 / Phase 22025-05-14
RecruitingPhase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA)
Sanfilippo Syndrome Type A
Phase 12024-11-21
Active Not RecruitingEvaluation of the Effectiveness and Safety of Rozetel Tablet in Patients After PCI: A Multi-Center Observation
Hypertension, Dyslipidemia
—2023-06-07
RecruitingA Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.
Hepatitis B
Phase 32023-04-13
UnknownA Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fed Conditions
Healthy Volunteers
Phase 12023-02-06
UnknownAn Open-label, Bridging Study of BARYCELA Inj. in Healthy Vietnamese Children Aged Between 12 Months to 12 Yea
Varicella Zoster Virus Infection
N/A2023-02-01
UnknownA Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fasting Conditions
Healthy Volunteers
Phase 12023-01-17
Active Not RecruitingA Study to Evaluate the Safety, Tolerability, PK and PD of Intracerebroventricular GC1123 in Patients with MPS
Mucopolysaccharidosis II, Hunter Syndrome
Phase 12022-09-20
CompletedA Phase 1b Study to Assess the Safety, Tolerability, PK and PD of MG1113 in Hemophilia Patient
Hemophilia
Phase 12022-08-24
Active Not RecruitingStudy of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficienc
Primary Immune Deficiency
Phase 32020-12-21
CompletedAn Extension Study to Assess the Long-term Safety and Efficacy of Hunterase (Idursulfase Beta)
MPS II, Hunter Syndrome (MPS II), Hunter Syndrome
Phase 32018-05-23